[1] |
Brent GA.Clinical practice. Graves' disease[J]. N Engl J Med, 2008, 358(24): 2594-2605.
|
[2] |
Bahn RS, Burch HB, Cooper DS, et al.Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists[J]. Endocr Pract, 2011, 17(3):456-520.
|
[3] |
王勤奋, 张成刚, 赵晓斌, 等. 1003例Graves'病131I治疗临床分析[J]. 中华核医学杂志,2005, 25(2):108-110.
|
[4] |
杨吉生, 王强, 胡明造, 等. 131I治疗Graves'病的最适剂量探讨[J]. 同位素,2000,13(3):177-181.
|
[5] |
蒋宁一, 匡安仁, 谭建, 等. 131I 治疗Graves'甲亢专家共识(2010)[J]. 中华核医学杂志,2010,30:346-351.
|
[6] |
赵永胜, 赵从雯, 黄铁军, 等. 碘-131治疗重度甲状腺肿大伴机能亢进症38例临床观察[J].第一军医大学学报, 2004, 24:591-593.
|
[7] |
Haase A, Bähre M, Lauer I, et al.Radioiodine therapy in Graves' hyperthyroidism: Determination of individual optimum target dose[J]. Exp Clin Endocrinol Diabetes,2000, 108(2):133-137.
|
[8] |
Sztal-Mazer S1, Nakatani VY, Bortolini LG, et al. Evidence for higher success rates and successful treatment eailier in Graves' disease with higher radioactive iodine doses[J]. Thyroid, 2012, 22(10):991-995.
|
[9] |
Neto AM, Tambascia MA, Brunetto S,et al.Extremely high doses of RAI required for treatment of Graves' hyperthyroidism: a case report[J]. Case J, 2009, 2:8479.
|
[10] |
Aleander EK, Larsen PR.High dose 131I therapy for the treatment of hyperthyroidism caused by Graves'disease[J]. J Clin Endocrinol Metab,2002, 87(3):1070-1077.
|
[11] |
潘明志, 管昌田. 131I治疗重度甲状腺肿大伴甲状腺功能亢进[J]. 华西医学, 1995,10(3):329-330.
|